Send us Feedback

Advanced Medical Optics (EYE)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
OPERATING METRICS
REVENUE SOURCES
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

EYE » Topics » Business Segments

This excerpt taken from the EYE 10-Q filed May 7, 2008.

Business Segments

 

     Net Sales    Operating Income (Loss)  
     Three Months Ended    Three Months Ended  

(In thousands)

    March 28,
2008		    March 30,
2007		    March 28,
2008		     March 30,
2007		  

Operating segments:

           

Cataract

    $ 124,299    $ 114,892    $ 63,777     $ 58,867  

Refractive

      120,450      77,472      74,616       48,699  

Eye Care

      58,987      59,309      20,550       21,616  
                              

Total segments

      303,736      251,673      158,943       129,182  

Global operations

      —        —        (43,385 )     (38,183 )

Research and development

      —        —        (19,906 )     (19,164 )

In-process research and development

      —        —        —         (1,580 )

Restructuring charges

      —        —        (11,936 )     —    

General corporate

      —        —        (54,348 )     (43,011 )
                              

Total

    $ 303,736    $ 251,673    $ 29,368     $ 27,244  
                              

 

15

Table of Contents
This excerpt taken from the EYE 10-Q filed May 9, 2007.

Business Segments

 

     Net Sales    Operating Income (Loss)  
     Three Months Ended    Three Months Ended  

(In thousands)

    March 30,
2007		    March 31,
2006		    March 30,
2007		     March 31,
2006		  

Operating segments:

           

Cataract/Implant

    $ 127,749    $ 120,444    $ 67,990     $ 55,266  

Laser Vision Correction

      64,615      60,955      39,576       42,860  

Eye Care

      59,309      56,829      21,616       21,363  
                              

Total segments

      251,673      238,228      129,182       119,489  

Manufacturing operations

      —        —        (10,655 )     (2,994 )

Research and development

      —        —        (19,164 )     (16,973 )

In-process research and development

      —        —        (1,580 )     —    

Business repositioning

      —        —        —         (32,432 )

Global supply chain

      —        —        (17,290 )     (13,812 )

General corporate

      —        —        (53,249 )     (43,551 )
                              

Total

    $ 251,673    $ 238,228    $ 27,244     $ 9,727  
                              

 

11

EXCERPTS ON THIS PAGE:

10-Q
May 7, 2008
10-Q
May 9, 2007

RELATED TOPICS for EYE:

"Business Segments" elsewhere:

BECTON DICKINSON & CO (BDX)
Memry (MRY)
Protherics (PTIL)
Teleflex (TFX)
West Pharmaceutical Services (WST)
Baxter International (BAX)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki